Sultan Nacak Baytas (Sultan Baytas)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Cell Cycle Arrest

Anti Inflammatory

Papillary Thyroid

Top Venues

Drug development research

Chemistry & biodiversity

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Gulseren Turhal, Busra Demirkan, Izel Nermin Baslilar, Nimet Sule Yuncu, Sultan Nacak Baytas, Asuman Demiroglu-Zergeroglu
Preliminary evaluation of antiproliferative and apoptotic activities of novel indolin-2-one derivatives. Drug development research 85 (5) (2024)
Peng He, Xing Zhang, Ke Xia, Dixy E Green, Sultan Nacak Baytas, Yongmei Xu, Truong Pham, Jian Liu, Fuming Zhang, Andrew Almond, Robert J Linhardt, Paul L DeAngelis
Chemoenzymatic synthesis of sulfur-linked sugar polymers as heparanase inhibitors. Nature communications 13 (1) (2022)
Mohammed Hawash, Deniz Cansen Kahraman, Sezen Guntekin Ergun, Rengul Cetin Atalay, Sultan Nacak Baytas
Synthesis of novel indole-isoxazole hybrids and evaluation of their cytotoxic activities on hepatocellular carcinoma cell lines. BMC chemistry 15 (1) (2021)
Mohammed Hawash, Deniz Cansen Kahraman, Rengul Cetin-Atalay, Sultan Nacak Baytas
Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Novel Indolylacrylamide Derivatives: Synthesis and Biological Evaluation. Chemistry & biodiversity 18 (5) (2021)
Nazan Inceler, Yesim Ozkan, Nilufer Nermin Turan, Deniz Cansen Kahraman, Rengul Cetin-Atalay, Sultan Nacak Baytas
Design, synthesis and biological evaluation of novel 1,3-diarylpyrazoles as cyclooxygenase inhibitors, antiplatelet and anticancer agents. MedChemComm 9 (5) (2018)